Highlights Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Real-time Estimate Cboe BZX Other stock markets 07:38:55 18/06/2024 pm IST			5-day change	1st Jan Change
475.4 ^USD	+0.36%		-1.60%	+16.45%

17/06	Argus Adjusts Price Target on Vertex Pharmaceuticals to $550 From $465	MT
14/06	Vertex Pharmaceuticals Says Gene-Editing Therapy Demonstrates Clinical Benefits in Genetic Disease Trials	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vertex Pharmaceuticals Says Gene-Editing Therapy Demonstrates Clinical Benefits in Genetic Disease Trials	14/06	MT
Vertex Pharmaceuticals Incorporated Presents Positive Long-Term Data on CASGEVY (Exagamglogene Autotemcel)	14/06	CI
Vertex Pharmaceuticals Says Phase 3 Data Show Trikafta Improves Lung Function in Cystic Fibrosis Patients	07/06	MT
Vertex Pharmaceuticals Incorporated Presents New Data at the European Cystic Fibrosis Conference Demonstrating Significant Benefits of Treatment with TRIKAFTA	07/06	CI
ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment	21/05	MT
Vertex Pharmaceuticals Incorporated completed the acquisition of Alpine Immune Sciences, Inc. from a group of shareholders.	20/05	CI
Alpine Immune Sciences, Vertex Pharmaceuticals Deal Crosses Another Milestone	11/05	MT
Vertex Pharmaceuticals Q1 Non-GAAP EPS, Revenue Increase	07/05	MT
Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drug	07/05	DJ
Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED Reports Q1 EPS $4.76, vs. Street Est of $4.06	07/05	MT
Vertex Pharmaceuticals Reiterates FY 2024 Total Product Revenue Guidance of $10.55-$10.75 Billion	07/05	MT
Vertex Pharmaceuticals Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05	CI
Vertex tops Q1 profit estimates on robust demand for cystic fibrosis treatments	07/05	RE
Vertex Pharmaceuticals Incorporated Re-Iterates Earnings Guidance for the Full Year 2024	07/05	CI
Equity Markets Higher as Traders Parse Fed Official's Remarks	07/05	MT
Futures Rise Pre-Bell Ahead of Latest Earnings Week; Asia Mostly Up, Europe Strong	06/05	MT
S&P 500 Posts Weekly Gain as Weaker-Than-Expected April Jobs Report Boosts Hopes for FOMC Rate Cut	04/05	MT
Vertex Pharmaceuticals Announces European Commission Approval for KALYDECO to Treat Infants with Cystic Fibrosis Ages 1 Month and Older	26/04	CI
Vertex Pharmaceuticals Says FDA Granted Rolling Review of Suzetrigine to Treat Acute Pain	18/04	MT
Health Care Slips on Risk Bias -- Health Care Roundup	12/04	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Highlights

Filters